{"id":"https://openalex.org/W2014951197","doi":"https://doi.org/10.1001/archderm.132.1.42","title":"Increased Serum Concentration of the Soluble Interleukin-2 Receptor in Cutaneous T-Cell Lymphoma","display_name":"Increased Serum Concentration of the Soluble Interleukin-2 Receptor in Cutaneous T-Cell Lymphoma","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2014951197","doi":"https://doi.org/10.1001/archderm.132.1.42","mag":"2014951197","pmid":"https://pubmed.ncbi.nlm.nih.gov/8546482"},"language":"en","primary_location":{"id":"doi:10.1001/archderm.132.1.42","doi":"https://doi.org/10.1001/archderm.132.1.42","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archderm.132.1.42","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062887811","display_name":"Mariusz A. Wasik","orcid":"https://orcid.org/0000-0002-1988-3670","observed_orcids":["https://orcid.org/0000-0002-1988-3670"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. A. Wasik","raw_affiliation_strings":["Department of Pathology, Beth Israel Hospital, Boston, Mass, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Beth Israel Hospital, Boston, Mass, USA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5062887811"],"corresponding_institution_ids":["https://openalex.org/I1316535847"],"apc_list":null,"apc_paid":null,"fwci":4.455,"has_fulltext":false,"cited_by_count":93,"citation_normalized_percentile":{"value":0.9435755,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"132","issue":"1","first_page":"42","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-il-2-receptor","display_name":"soluble interleukin-2 receptor","score":0.9340000152587891},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/mycosis-fungoides","display_name":"mycosis fungoides","score":0.9580000042915344},{"id":"https://openalex.org/keywords/sezary-syndrome","display_name":"S\u00e9zary syndrome","score":0.8240000009536743},{"id":"https://openalex.org/keywords/tumor-burden","display_name":"tumor burden","score":0.8870000243186951},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7289999723434448},{"id":"https://openalex.org/keywords/survival-prediction","display_name":"survival prediction","score":0.7820000052452087},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.7820000052452087},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2777756187","wikidata":"https://www.wikidata.org/wiki/Q1891209","display_name":"Mycosis fungoides","level":3,"score":0.8028433918952942},{"id":"https://openalex.org/C2776780870","wikidata":"https://www.wikidata.org/wiki/Q5196687","display_name":"Cutaneous T-cell lymphoma","level":4,"score":0.7948145866394043},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7864072918891907},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6670970320701599},{"id":"https://openalex.org/C2777318727","wikidata":"https://www.wikidata.org/wiki/Q409464","display_name":"Lactate dehydrogenase","level":3,"score":0.652239203453064},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.4988725185394287},{"id":"https://openalex.org/C2777891184","wikidata":"https://www.wikidata.org/wiki/Q7168693","display_name":"Peripheral T-cell lymphoma","level":4,"score":0.48784899711608887},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46495020389556885},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44691428542137146},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.43447959423065186},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43235641717910767},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4132135212421417},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37913569808006287},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2667270004749298},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11080050468444824},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007770","descriptor_name":"L-Lactate Dehydrogenase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016410","descriptor_name":"Lymphoma, T-Cell, Cutaneous","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016410","descriptor_name":"Lymphoma, T-Cell, Cutaneous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016410","descriptor_name":"Lymphoma, T-Cell, Cutaneous","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1001/archderm.132.1.42","doi":"https://doi.org/10.1001/archderm.132.1.42","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archderm.132.1.42","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},{"id":"doi:10.1001/archderm.1996.03890250052009","doi":"https://doi.org/10.1001/archderm.1996.03890250052009","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archderm.1996.03890250052009","pdf_url":null,"source":{"id":"https://openalex.org/S115046667","display_name":"Archives of Dermatology","issn_l":"0003-987X","issn":["0003-987X","1538-3652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of Dermatology","raw_type":"journal-article"},{"id":"pmid:8546482","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8546482","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G1496053919","display_name":"MOLECULAR CHARACTERIZATION OF CUTANEOUS T CELL LYMPHOMA","funder_award_id":"R29CA055017","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2996668482","display_name":"ANTIIDIOTYPE ANTIBODIES IN CUTANEOUS T-CELL LYMPHOMA","funder_award_id":"R01AR040404","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G6606243557","display_name":"CUTANEOUS MODEL OF LYMPHOMAGENESIS","funder_award_id":"R01CA054062","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W2493965","https://openalex.org/W116741446","https://openalex.org/W149648231","https://openalex.org/W156875203","https://openalex.org/W176755457","https://openalex.org/W179901198","https://openalex.org/W241897151","https://openalex.org/W1493823777","https://openalex.org/W1534418440","https://openalex.org/W1586739835","https://openalex.org/W1904295999","https://openalex.org/W1981846174","https://openalex.org/W1982938343","https://openalex.org/W1999692230","https://openalex.org/W2002941737","https://openalex.org/W2012467309","https://openalex.org/W2015376615","https://openalex.org/W2015923996","https://openalex.org/W2028415674","https://openalex.org/W2036110122","https://openalex.org/W2041046834","https://openalex.org/W2041530089","https://openalex.org/W2053702808","https://openalex.org/W2058275045","https://openalex.org/W2071112640","https://openalex.org/W2073449976","https://openalex.org/W2076756747","https://openalex.org/W2133811759","https://openalex.org/W2161033866","https://openalex.org/W2322136246","https://openalex.org/W2346164771","https://openalex.org/W2413900776","https://openalex.org/W2470157360","https://openalex.org/W4234047742","https://openalex.org/W4240841644","https://openalex.org/W4248715471"],"related_works":["https://openalex.org/W2118304583","https://openalex.org/W4242280397","https://openalex.org/W2087527693","https://openalex.org/W4301887498","https://openalex.org/W1996585585","https://openalex.org/W2282893556","https://openalex.org/W2044656530","https://openalex.org/W2117938873","https://openalex.org/W2992600578","https://openalex.org/W179901198"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"DESIGN:":[2],"The":[3,24,67,87],"serum":[4,25,55,136,168,202],"concentration":[5,26,94,137,169,203],"of":[6,27,44,47,70,82,89,111,140,158,179,196,199],"soluble":[7],"alpha-chain":[8],"receptor":[9],"for":[10],"interleukin-2":[11],"(sIL-2R)":[12],"was":[13,75,132,175],"determined":[14,36],"in":[15,64,72,100,102,149,164,210],"101":[16],"patients":[17,90,211],"with":[18,31,91,172,212],"cutaneous":[19],"T-cell":[20],"lymphoma":[21],"(CTCL).":[22],"RESULTS:":[23],"sIL-2R":[28,71,93,135,167,201],"correlates":[29],"positively":[30],"CTCL":[32,74,101],"tumor":[33,122,206],"burden":[34,207],"as":[35],"by":[37,54,60],"several":[38],"clinical":[39,42,109],"parameters":[40],"(ie,":[41],"subtype":[43],"disease,":[45],"extent":[46],"skin":[48,150],"involvement,":[49],"T":[50],"rating,":[51],"and":[52,59,125,138,152,174,208],"stage),":[53],"lactate":[56,187],"dehydrogenase":[57,188],"concentration,":[58],"S\u00e9zary":[61,183],"cell":[62,184],"counts":[63],"erythrodermic":[65,73,126,165],"disease.":[66],"median":[68],"value":[69],"more":[76],"than":[77,80,181],"threefold":[78],"higher":[79],"that":[81,163],"classic":[83],"mycosis":[84],"fungoides":[85],"(MF).":[86],"proportion":[88],"elevated":[92],"(>":[95],"1000":[96],"U/mL)":[97],"also":[98],"increased":[99],"a":[103,176],"similar":[104],"fashion":[105],"according":[106],"to":[107,204],"the":[108,194,197,200],"type":[110],"disease":[112],"(MF":[113],"patch":[114],"phase,":[115,119,123],"15%;":[116],"MF":[117,121],"plaque":[118],"33%;":[120],"47%;":[124],"variants,":[127],"90%).":[128],"However,":[129],"no":[130],"correlation":[131],"found":[133],"between":[134],"expression":[139],"membrane-bound":[141],"IL-2R":[142],"alpha":[143],"chain":[144],"(CD25)":[145],"on":[146],"lymphoid":[147],"cells":[148],"lesions":[151],"peripheral":[153],"blood.":[154],"Significantly,":[155],"multivariate":[156],"analysis":[157],"various":[159],"prognostic":[160],"factors":[161],"demonstrated":[162],"CTCL,":[166],"correlated":[170],"best":[171],"survival":[173],"better":[177],"predictor":[178],"prognosis":[180,209],"stage,":[182],"counts,":[185],"or":[186],"values.":[189],"CONCLUSIONS:":[190],"These":[191],"findings":[192],"document":[193],"usefulness":[195],"measurement":[198],"determine":[205],"CTCL.":[213]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}
